selected publications
-
article
- Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: Results of a multicentre, double-blind, randomised-withdrawal trial. Annals of the Rheumatic Diseases. 77:21-29. 2018-01-01
- Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis. Arthritis and Rheumatism. 62:1792-1802. 2010-01-01